Generally, the compositions in the form of the liposomes can contain, in addition to the compound of the muramyl-peptide type, any constituents: stabilizers, preservatives, excipients or other active substances capable of being used in the injectable solutions or emulsions presented previously for administration of muramyl-peptide compounds, provided that they are compatible with this liposome for